University Hospital of South Manchester awarded Centre of Excellence status
January 11 2017
The University Hospital of South Manchester is to become the first hospital in the UK and Europe to be recognised as a centre of excellence for the diagnosis and treatment of aspergillosis and other fungal infections.
The European Confederation of Medical Mycology (ECMM) Centre of Excellence scheme (see here for more details) will provide a network of centres able to direct physicians, patients and relatives to an appropriate and capable centre. The Mycology Reference Centre Manchester (MRCM) based at the University of Manchester, in partnership with the National Aspergillosis Centre (NAC) at UHSM’s Wythenshawe Hospital is therefore the first of many across Europe to receive this award. It recognises their collaboration in better understanding medical issues related to mycology.
The MRCM, under the leadership of Professor Malcolm Richardson provides a specialist National Health Service Medical Mycology Reference Service to patients throughout the UK and acts as a focus for national and international training and research in Medical Mycology in the UK. The National Aspergillosis Centre (NAC), the first national centre for aspergillosis in the world, is based at Wythenshawe Hospital. This service, led by Professor David Denning, benefits patients across the UK, by building on the extensive expertise in chronic fungal lung infections with sophisticated laboratory support provided by the MRCM.
While there have been some significant improvements in diagnostic tests and therapeutic choices for fungal diseases over the last 15 years, access to appropriate diagnostics and treatment is far from universal within Europe and globally. The network of ECMM Centres of Excellence will help to address inadequate expertise in clinical management and diagnostic capability.
The inauguration of the European Confederation of Medical Mycology (ECMM) Centre of Excellence scheme is taking place at the University Hospital of South Manchester (UHSM) on Wednesday January 11, 2017.